Roadmap to eliminate gastric cancer with Helicobacter pylori eradication and consecutive surveillance in Japan Masahiro AsakaMototsugu KatoNaoya Sakamoto Review Open access 27 October 2013 Pages: 1 - 8
The EGFR signalling system in the liver: from hepatoprotection to hepatocarcinogenesis Carmen BerasainMatías A. Avila Review 10 December 2013 Pages: 9 - 23
Physiology, signaling, and pharmacology of opioid receptors and their ligands in the gastrointestinal tract: current concepts and future perspectives Marta SobczakMaciej SałagaJakub Fichna Review Open access 09 February 2013 Pages: 24 - 45
Clinical application of 18F-fluorodeoxyglucose positron emission tomography for assessment and evaluation after therapy for malignant hepatic tumor Masakatsu TsurusakiMasahiko OkadaTakamichi Murakami Review Open access 26 March 2013 Pages: 46 - 56
Current status of bariatric surgery in Japan and effectiveness in obesity and diabetes Akira SasakiGo WakabayashiYoshikazu Yonei Review Open access 18 April 2013 Pages: 57 - 63
Pathological diagnosis of flat epithelial lesions of the biliary tract with emphasis on biliary intraepithelial neoplasia Yasunori SatoMotoko SasakiHepatolithiasis Subdivision of Intractable Hepatobiliary Diseases Study Group of Japan (Chairman, Hirohito Tsubouchi) Review 25 April 2013 Pages: 64 - 72
The ability of a novel blue laser imaging system for the diagnosis of invasion depth of colorectal neoplasms Naohisa YoshidaTakashi HisabeYuji Naito Original Article—Alimentary Tract 15 March 2013 Pages: 73 - 80
C-ERC/mesothelin provokes lymphatic invasion of colorectal adenocarcinoma Futoshi KawamataShigenori HommaSatoru Todo Original Article—Alimentary Tract 20 March 2013 Pages: 81 - 92
Evaluation of diagnostic criteria for Crohn’s disease in Japan Takashi HisabeFumihito HiraiMamoru Watanabe Original Article—Alimentary Tract 03 April 2013 Pages: 93 - 99
Clinical utility of newly developed immunoassays for serum concentrations of adalimumab and anti-adalimumab antibodies in patients with Crohn’s disease Hirotsugu ImaedaKenichiro TakahashiAkira Andoh Original Article—Alimentary Tract 11 April 2013 Pages: 100 - 109
Photodynamic therapy for human hepatoma-cell–line tumors utilizing biliary excretion properties of indocyanine green Junichi KanekoYoshinori InagakiNorihiro Kokudo Original Article—Liver, Pancreas, and Biliary Tract 18 April 2013 Pages: 110 - 116
Positive glypican-3 expression in early hepatocellular carcinoma predicts recurrence after hepatectomy I-Pei ChenShun-ichi AriizumiMasakazu Yamamoto Original Article—Liver, Pancreas, and Biliary Tract Open access 27 March 2013 Pages: 117 - 125
Ex vivo induction of IFN-λ3 by a TLR7 agonist determines response to Peg-IFN/Ribavirin therapy in chronic hepatitis C patients Kazumoto MurataMasaya SugiyamaMasashi Mizokami Original Article—Liver, Pancreas, and Biliary Tract Open access 17 April 2013 Pages: 126 - 137
Once-daily simeprevir (TMC435) with peginterferon/ribavirin for treatment-naïve hepatitis C genotype 1-infected patients in Japan: the DRAGON study Norio HayashiChiharu SetoShoichiro Goto Original Article—LIVER, PANCREAS, AND BILIARY TRACT Open access 05 September 2013 Pages: 138 - 147
Impact of hospital volume on outcomes in acute pancreatitis: a study using a nationwide administrative database Tsuyoshi HamadaHideo YasunagaKazuhiko Koike Original Article—Liver, Pancreas, and Biliary Tract 11 October 2013 Pages: 148 - 155
The 2nd edition of consensus statements for the diagnosis and management of intestinal Behçet’s disease: indication of anti-TNFα monoclonal antibodies Tadakazu HisamatsuFumiaki UenoToshifumi Hibi Rapid Communication Open access 18 August 2013 Pages: 156 - 162
Once-daily simeprevir in combination with pegylated-interferon and ribavirin: a new horizon in the era of direct-acting antiviral agent therapy for chronic hepatitis C Shinya MaekawaNobuyuki Enomoto Editorial 21 December 2013 Pages: 163 - 164